Leaflet ICALZISS 340mmol / l solution for infusion

Indicated for: calcium deficiency; osteoporosis

Route of administration: infusion

Substance: calcium chloride (calcium salt)

ATC: B05XA07 (Blood and blood forming organs | I.v. solution additives | Electrolyte solutions)

Precautions:
Avoid milk, calcium, iron, or antacids
Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

Calcium chloride is a medication used for the treatment of acute hypocalcemia, hyperkalemia, hypermagnesemia, and calcium channel blocker overdose. It provides calcium, an essential mineral for the normal functioning of the nervous, muscular, and cardiovascular systems, as well as for blood coagulation and bone health.

The medication is administered intravenously, usually as a slow injection or infusion, as directed by a doctor. The dosage is adjusted based on the severity of the condition and the patient's response to treatment.

Common side effects include a sensation of warmth, metallic taste, nausea, and irritation at the injection site. In rare cases, more severe adverse effects such as cardiac arrhythmias, hypercalcemia, or tissue necrosis in cases of extravascular administration may occur.

Calcium chloride is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, administration should be performed by qualified medical personnel to minimize the risks associated with this medication.

General data about ICALZISS 340mmol / l

  • Substance: calcium chloride
  • Date of latest medicines list: 01-06-2025
  • Product code: W71072001
  • Concentration: 340mmol / l
  • Pharmaceutical form: solution for infusion
  • Quantity: 20
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: BIEFFE MEDITAL S.P.A. - SPANIA
  • Holder: VANTIVE BELGIUM SRL - BELGIA
  • Number: 15975/2025/01
  • Shelf life: 1 year-after packing for marketing;Dupa prima deschidere a pungii-72 h

Pharmaceutical forms available for calcium chloride

Concentrations available for calcium chloride

  • 100mmol/l
  • 12.2%
  • 340mmol/l